Wachtell and Skadden lead Pfizer/Array deal

Spencer Parts

18 June 2019

Pfizer has announced that it will purchase Colorado-based Array Pharmaceuticals in an $11 billion acquisition that adds to Pfizer’s cancer treatment portfolio.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Spencer Parts

View full biography

Author

Tipline

In low Spirits: The Tipline for 6 December 2023
JetBlue’s lawyers had a lot to smile about during closing arguments. The judge presiding over the Department of Justice’s challenge to JetBlue/Spirit said he was “having problems" with blocking a deal in such a dynamic industry. But investors seemed less enthused. JetBlue’s stock dropped nearly 4% on Tuesday while Spirit’s fell more than 12% to $13.67 a share – a fraction of the $33.50 a share JetBlue committed to paying last June.
For St Pete’s Sake: The Tipline for 5 December 2023
Bidding adieu to bid competition: The Tipline for 4 December 2023